|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,066,843 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,005,693 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 27 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-02-03 |
4 |
AS |
$83.50 |
$835,000 |
D/D |
(10,000) |
328,530 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-15 |
4 |
D |
$83.57 |
$1,245,862 |
D/D |
(14,908) |
249,766 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-19 |
4 |
AS |
$83.58 |
$585,060 |
D/D |
(7,000) |
295,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-04-20 |
4 |
AS |
$83.65 |
$836,458 |
D/D |
(10,000) |
290,031 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-04-14 |
4 |
AS |
$83.66 |
$836,600 |
D/D |
(10,000) |
334,983 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-04-28 |
4 |
AS |
$83.79 |
$1,675,800 |
D/D |
(20,000) |
334,983 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-12-29 |
4 |
AS |
$83.84 |
$335,360 |
D/D |
(4,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-03-15 |
4 |
D |
$83.87 |
$7,146,479 |
D/D |
(85,209) |
474,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-26 |
4 |
AS |
$84.00 |
$420,000 |
D/D |
(5,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-12-28 |
4 |
AS |
$84.04 |
$252,120 |
D/D |
(3,000) |
288,290 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-05-05 |
4 |
AS |
$84.14 |
$841,400 |
D/D |
(10,000) |
335,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-03-01 |
4 |
AS |
$84.22 |
$842,769 |
D/D |
(10,000) |
340,500 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-10-17 |
4 |
AS |
$84.39 |
$3,516,227 |
D/D |
(41,666) |
323,368 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-01-25 |
4 |
AS |
$84.44 |
$422,200 |
D/D |
(5,000) |
170,682 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-01-07 |
4 |
AS |
$84.46 |
$253,380 |
D/D |
(3,000) |
327,530 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-03-13 |
4 |
D |
$84.50 |
$2,615,444 |
D/D |
(30,952) |
265,491 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-17 |
4 |
AS |
$84.54 |
$676,320 |
D/D |
(8,000) |
295,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-02-15 |
4 |
AS |
$84.63 |
$846,285 |
D/D |
(10,000) |
226,494 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-12-16 |
4 |
AS |
$84.68 |
$508,080 |
D/D |
(6,000) |
303,689 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-03-15 |
4 |
AS |
$84.73 |
$1,270,901 |
D/D |
(15,000) |
264,674 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-08-02 |
4 |
S |
$84.73 |
$31,943 |
D/D |
(377) |
7,055 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-01-08 |
4 |
AS |
$84.92 |
$339,680 |
D/D |
(4,000) |
327,530 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-06-28 |
4 |
A |
$84.96 |
$16,567 |
D/D |
195 |
8,779 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-02 |
4 |
AS |
$85.01 |
$3,102,931 |
D/D |
(36,500) |
395,635 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-02-18 |
4 |
AS |
$85.08 |
$595,560 |
D/D |
(7,000) |
295,552 |
0 |
- |
|
852 Records found
|
|
Page 27 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|